Genetic Technologies Ltd
NASDAQ:GENE

Watchlist Manager
Genetic Technologies Ltd Logo
Genetic Technologies Ltd
NASDAQ:GENE
Watchlist
Price: 0.765 USD Market Closed
Market Cap: 2.5m USD

Wall Street
Price Targets

GENE Price Targets Summary
Genetic Technologies Ltd

There are no price targets for GENE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Genetic Technologies Ltd Competitors:
Price Targets
BRKR
Bruker Corp
7% Upside
DIVISLAB
Divi's Laboratories Ltd
6% Upside
1521
Frontage Holdings Corp
22% Upside
ERF
Eurofins Scientific SE
6% Upside
IQV
IQVIA Holdings Inc
14% Upside
4880
CellSource Co Ltd
124% Upside
HYFT
Immunoprecise Antibodies Ltd
137% Upside
LONN
Lonza Group AG
28% Upside

Revenue
Forecast

Revenue Estimate
Genetic Technologies Ltd

For the last 12 years the compound annual growth rate for Genetic Technologies Ltd's revenue is 6%. The projected CAGR for the next 10 years is 0%.

6%
Past Growth
0%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Genetic Technologies Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Genetic Technologies Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GENE's stock price target?
Not Available

GENE doesn't have any price targets made by Wall Street professionals.

What is Genetic Technologies Ltd's Revenue forecast?
Projected CAGR
0%

For the last 12 years the compound annual growth rate for Genetic Technologies Ltd's revenue is 6%. The projected CAGR for the next 10 years is 0%.

Back to Top